Drugmaker Vivus Inc. (NASDAQ:VVUS) said 12 June Thursday it has filed a lawsuit against Actavis PLC and its affiliates in a New Jersey federal court over its bid with the U.S. Food and Drug Administration to sell a generic version of Vivus’ prescription weight-loss drug Qsymia. VIVUS, Inc. (NASDAQ:VVUS) weekly performance is -0.38%. On last trading day company shares ended up $5.18. Analysts mean target price for the company is $7.33. VIVUS, Inc. (NASDAQ:VVUS) distance from 50-day simple moving average (SMA50) is 1.89%.
Arena Pharmaceuticals, Inc. (NASDAQ:ARNA) is a bio-pharmaceutical company that mainly focuses on discovering, developing as well as commercializing drugs, and primarily targets G protein-coupled receptors. On June 13, 2014 the major pharmaceutical company announced that it is programmed to present a corporate overview on Wednesday, June 18, 2014. Arena Pharmaceuticals, Inc. (NASDAQ:ARNA) shares fell -3.38% in last trading session and ended the day on $6.28. ARNA gross Margin is 93.70% and its return on assets is -8.10%.Arena Pharmaceuticals, Inc. (NASDAQ:ARNA) quarterly performance is -2.18%.
Auxilium Pharmaceuticals Inc. (NASDAQ:AUXL) on 11 June has formed a partnership with Ohio-based Prasco LLC to introduce an “authorized” generic version of its flagship Testim product. Auxilium Pharmaceuticals, Inc. (NASDAQ:AUXL) shares moved up 1.47% in last trading session and was closed at $21.45, while trading in range of $21.00 – $21.99. Auxilium Pharmaceuticals, Inc. (NASDAQ:AUXL) year to date (YTD) performance is 3.47%.
Athersys, Inc.’s (NASDAQ:ATHX) on 14 may reported, first quarter 2014 net loss of 15 cents per share was wider than the Zacks Consensus Estimate of a loss of 9 cents. The company had suffered a loss of 18 cents per share in the year-ago quarter. Revenues increased to $0.7 million from $0.3 million recorded a year ago, driven by higher grant revenues. Athersys, Inc. (NASDAQ:ATHX) ended the last trading day at $1.64. Company weekly volatility is calculated as 5.33% and price to cash ratio as 2.81.Athersys, Inc. (NASDAQ:ATHX) showed a negative weekly performance of -1.20%.
Micromem Technologies Inc. (OTCBB:MMTIF) through its wholly owned subsidiary Micromem Applied Sensor Technologies Inc. (MAST), on 21 April announces manufacturing has begun for client orders of our nanoparticle detection platform (the “Detector”). On last trading day company shares ended up $0.607.